SEB Asset Management’s Edgewise Therapeutics EWTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$9.8M Buy
241,488
+47,425
+24% +$2.02M 0.04% 329
2026
Q2
$7.88M Sell
194,063
-12,449
-6% -$429K 0.03% 378
2026
Q1
$6.51M Buy
+206,512
New +$5.96M 0.03% 408

Other funds holding EWTX

SEB Asset Management's EWTX Position: Q3 2026 in Review

SEB Asset Management increased its Edgewise Therapeutics (EWTX) stake by 24% in Q3 2026, buying an estimated $2.02M and bringing the position to 241,488 shares worth $9.8M. The position accounts for 0.04% of the portfolio, ranked #329.

SEB Asset Management first reported a position in EWTX in Q1 2026 and has held it in 3 quarters since. 252 funds tracked by Wall St. Rank hold EWTX as of Q3 2026.

  • SEB Asset Management held 241,488 shares of Edgewise Therapeutics worth $9.8M as of Q3 2026.
  • SEB Asset Management bought 47,425 Edgewise Therapeutics shares in Q3 2026, an estimated $2.02M.
  • Edgewise Therapeutics made up 0.04% of SEB Asset Management's portfolio in Q3 2026, its #329 holding.
  • SEB Asset Management first reported a position in Edgewise Therapeutics in Q1 2026 and has held it in 3 quarters since.
  • 252 funds tracked by Wall St. Rank held Edgewise Therapeutics as of Q3 2026.

Based on SEB Asset Management's 13F filing for Q3 2026, filed 4 Nov 2026.